These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 45850)

  • 1. The complement system in bullous pemphigoid. II. Immunofluorescent evidence for both classical and alternate-pathway activation.
    Jordon RE; Schroeter AL; Good RA; Day NK
    Clin Immunol Immunopathol; 1975 Jan; 3(3):307-14. PubMed ID: 45850
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for the activation of complement via the alternate pathway in skin diseases. II. Dermatitis herpetiformis.
    Provost TT; Tomasi TB
    Clin Immunol Immunopathol; 1974 Nov; 3(2):178-86. PubMed ID: 4217677
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunofluorescent studies in mucous membrane pemphigoid.
    Griffith MR; Fukuyama K; Tuffanelli D; Silverman S
    Arch Dermatol; 1974 Feb; 109(2):195-9. PubMed ID: 4205499
    [No Abstract]   [Full Text] [Related]  

  • 4. Classical and alternate pathway activation of complement in pemphigus vulgaris lesions.
    Jordon RE; Schroeter AL; Rogers RS; Perry HO
    J Invest Dermatol; 1974 Sep; 63(3):256-9. PubMed ID: 4211874
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for complement activation via the alternate pathway in skin diseases, I. Herpes gestationis, systemic lupus erythematosus, and bullous pemphigoid.
    Provost TT; Tomasi TB
    J Clin Invest; 1973 Jul; 52(7):1779-87. PubMed ID: 4352464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in bullous skin diseases.
    Jordon RE
    J Invest Dermatol; 1975 Jul; 65(1):162-9. PubMed ID: 50385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct immunofluorescent studies of pemphigus and bullous pemphigoid.
    Jordon RE; Triftshauser CT; Schroeter AL
    Arch Dermatol; 1971 May; 103(5):486-91. PubMed ID: 4931648
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration of basement membrane autoantibodies in patients with benign mucous membrane pemphigoid.
    Dabelsteen E; Ullman S; Thomsen K; Rygaard J
    Acta Derm Venereol; 1974; 54(3):189-92. PubMed ID: 4134127
    [No Abstract]   [Full Text] [Related]  

  • 9. Benign mucous membrane pemphigoid: demonstration of circulating and tissue-bound membrane antibodies.
    Tagami H; Imamura S
    Arch Dermatol; 1974 May; 109(5):711-3. PubMed ID: 4597560
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis.
    Seah PP; Fry L; Mazaheri MR; Mowbray JF; Hoffbrand AV; Holborow EJ
    Lancet; 1973 Jul; 2(7822):175-7. PubMed ID: 4124252
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of circulating antibodies reactive with basal cells of skin in drug reactions.
    van Joost T
    Acta Derm Venereol; 1974; 54(3):183-7. PubMed ID: 4134658
    [No Abstract]   [Full Text] [Related]  

  • 12. Herpes gestationis. New immunologic findings.
    Bushkell LL; Jordon RE; Goltz RW
    Arch Dermatol; 1974 Jul; 110(1):65-9. PubMed ID: 4608100
    [No Abstract]   [Full Text] [Related]  

  • 13. The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.
    Jordon RE; Day NK; Sams WM; Good RA
    J Clin Invest; 1973 May; 52(5):1207-14. PubMed ID: 4573354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined immunofluorescent staining for the simultaneous detection of anti-DNP antibody and immunoglobulin class in the same cell.
    Emmings FG; Genco RJ
    J Immunol Methods; 1974 Oct; 5(4):323-35. PubMed ID: 4139219
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoglobulins and complement C' 3 in lichen amyloidosus. Immunofluorescent study.
    Stringa SG; Bianchi C; Casala A; Bianchi O
    Arch Dermatol; 1972 Apr; 105(4):541-3. PubMed ID: 4111676
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating autoantibodies in ocular pemphigoid.
    Waltman SR; Yarian D
    Am J Ophthalmol; 1974 Jun; 77(6):891-4. PubMed ID: 4209155
    [No Abstract]   [Full Text] [Related]  

  • 17. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
    May JE; Frank MM
    J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunopathology of lupus erythematosus: a comparison of immunohistochemical techniques. I. Immunofluorescence.
    Tuffanelli DL
    Adv Biol Skin; 1971; 11():287-94. PubMed ID: 4124142
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin.
    Provost TT; Tomasi TB
    Clin Exp Immunol; 1974 Oct; 18(2):193-200. PubMed ID: 4619597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative studies of immunofluorescent staining. 3. Comparison of different antigens in an indirect immunofluorescent staining system for human IgG using the basement zone antibodies of bullous pemphigoid.
    Wick G; Beutner EH
    Immunology; 1969 Feb; 16(2):149-56. PubMed ID: 4976938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.